Clinical Trials Browser

Phase 2 × Glioblastoma × Gefitinib × Clear all

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT01310855 2017-05-31

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Terminated

38 enrolled 8 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00014170 2013-07-16

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Completed

92 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00016991 2013-06-20

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Phase 2 Completed

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00238797 2011-01-21

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

Phase 2 Completed

36 enrolled

CNS

Brain Neoplasms, Glioblastoma

Clinical Trials

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme